Word: highnesses
(lookup in dictionary)
(lookup stats)
Dates: during 1950-1959
Sort By: most recent first
(reverse)
...Steelmakers plan to operate at about 95% of capacity this week, and output should top the industry's alltime record reached last April. Imports of steel also eased slightly in October, but stayed at a high level of 362,000 tons for the month. ¶ Freight carloadings rose 75,513 cars above the previous week, outpacing the same week in both...
Steel. Joseph L. Block, chairman of Inland Steel, predicted that, barring a new strike, the nation's mills will pour 70 million ingot tons in the first half, 130 million during the whole year, up from 92 million in 1959 and above the alltime high of 117 million...
...drug industry would like to appear as a dedicated, white-coated scientist skillfully brewing one wonder drug after another. But Tennessee's Estes Kefauver, chairman of the Senate Antitrust Subcommittee, long has had ambitions to paint a different picture -of an industry that fixes prices too high. Last week, opening an investigation of drugmakers, the Keef got in his broad strokes as soon as nervous industry witnesses settled uncomfortably in their hot seats...
...choosing Schering as his initial target, Senator Kefauver picked a good example of the high-profit potential of the drug industry. Set up in Bloomfield, N.J., in 1935 by Germans to make sex hormones, Schering had only $3,000,000 in annual sales when the Government confiscated the company in 1942, and put Francis Brown, then a young Government attorney, in charge. The Government sold the company for $29 million in 1952, and within five years its yearly net exceeded that. But success was not guaranteed. A year after the stock went on the market at $17.50, it dropped...
...Many Pitchmen? One of the biggest reasons for the high cost of medicines is the growing army of salesmen. The major drug firms employ an estimated 20,000, or one for every ten physicians, and they make 18 million calls a year to get doctors to prescribe and druggists to stock their products. Is this necessary? No, said Dr. Louis Lasagna, head of clinical pharmacology at Johns Hopkins. Too many new drugs, he said, often are "not as good as what they replace...